Viva Biotech Holdings (1873.HK)

HKD 0.89

(-2.2%)

Net Debt Summary of Viva Biotech Holdings

Viva Biotech Holdings's latest annual net debt in 2023 was 866.89 Million CNY , down -59.57% from previous year.
Viva Biotech Holdings's latest quarterly net debt in 2024 Q2 was 475.43 Million CNY , down 0.0% from previous quarter.
Viva Biotech Holdings reported annual net debt of 2.14 Billion CNY in 2022, up 15.68% from previous year.
Viva Biotech Holdings reported annual net debt of 1.85 Billion CNY in 2021, up 180.42% from previous year.
Viva Biotech Holdings reported quarterly net debt of 866.89 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Viva Biotech Holdings reported quarterly net debt of 866.89 Million CNY for 2023 FY, down -59.57% from previous quarter.

Annual Net Debt Chart of Viva Biotech Holdings (2023 - 2016)

Historical Annual Net Debt of Viva Biotech Holdings (2023 - 2016)

Year	Net Debt	Net Debt Growth
2023	866.89 Million CNY	-59.57%
2022	2.14 Billion CNY	15.68%
2021	1.85 Billion CNY	180.42%
2020	661.05 Million CNY	177.35%
2019	-854.68 Million CNY	-1367.93%
2018	67.4 Million CNY	554.81%
2017	-14.82 Million CNY	-49.42%
2016	-9.91 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	475.43 Million CNY	0.0%
2023 Q4	866.89 Million CNY	0.0%
2023 FY	866.89 Million CNY	-59.57%
2023 Q2	1.83 Billion CNY	0.0%
2022 FY	2.14 Billion CNY	15.68%
2022 Q4	2.14 Billion CNY	0.0%
2022 Q2	2.09 Billion CNY	0.0%
2021 Q2	1.7 Billion CNY	0.0%
2021 FY	1.85 Billion CNY	180.42%
2021 Q4	1.85 Billion CNY	0.0%
2020 Q4	661.05 Million CNY	0.0%
2020 FY	661.05 Million CNY	177.35%
2020 Q2	-946.57 Million CNY	0.0%
2019 Q4	-854.68 Million CNY	0.0%
2019 Q2	-1.19 Billion CNY	0.0%
2019 FY	-854.68 Million CNY	-1367.93%
2018 Q4	67.4 Million CNY	0.0%
2018 FY	67.4 Million CNY	554.81%
2017 FY	-14.82 Million CNY	-49.42%
2016 FY	-9.91 Million CNY	0.0%

Peer Net Debt Comparison of Viva Biotech Holdings

Name	Net Debt	Net Debt Difference
Uni-Bio Science Group Limited	-76.36 Million HKD	1235.14%
CK Life Sciences Int'l., (Holdings) Inc.	5.26 Billion HKD	83.54%